San Francisco: NAC Trial Recruiting CDC Daily UpdateImportant note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow



San Francisco: NAC Trial Recruiting

AIDS Treatment News (10/01/93) No. 184, P. 7


Herzenberg Laboratory at Stanford University is now recruiting for participants in an eight-week trial of NAC (N- acetylcysteine). The goal of the study is to determine whether oral NAC can replenish glutathione levels in the T cells of HIV-infected persons. Low glutathione levels are often characteristic of HIV infection, and it is thought that these low levels may cause T cells to function less efficiently and cause faster HIV replication. Volunteers may not already be taking NAC, OTC, cysteine, or glutathione, and must meet other medical requirements.


931026
AD931932


Copyright © 1993 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.